# Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rivaroxaban-reduces-arterial-thrombosis-by-inhibition-of-fxa-driven-platelet/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tobias Petzold,Manuela Thienel,Lisa Dannenberg,Philipp Mourikis,Carolin Helten,Aysel Ayhan,René M’Pembele,Alina Achilles,Kajetan Trojovky,Daniel Konsek,Zhe Zhang,Ron Regenauer,Joachim Pircher,Andreas Ehrlich,Enzo Lüsebrink,Leo Nicolai,Thomas J. Stocker,Richard Brandl,Franz Röschenthaler,Jan Strecker,Inas Saleh,Michael Spannagl,Christoph H. Mayr,Herbert B. Schiller,Christian Jung,Norbert Gerdes,Till Hoffmann,Bodo Levkau,Thomas Hohlfeld,Tobias Zeus,Christian Schulz,Malte Kelm,Amin Polzin |
| Citations | 122 |
| DOI | 10.1161/circresaha.119.315099 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.119.315099 |
| OpenAlex ID | https://openalex.org/W2995526000 |
| PMID | 31859592 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Tobias Petzold](https://scholariq.org/researchers/tobias-petzold/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.